You are leaving the Blue Earth Therapeutics website. By clicking this link, you will be taken to a website that is independent from Blue Earth Therapeutics. The site you are linking to is not controlled or endorsed by Blue Earth Therapeutics and Blue Earth Therapeutics is not responsible for the content provided on that site.
Blue Earth Therapeutics is a clinical stage radiopharmaceutical company dedicated to the advancement of next generation targeted radiotherapeutics to treat cancer patients. With proven leadership and therapeutic radiopharmaceutical expertise, Blue Earth Therapeutics has a strong pipeline of precision targeted radiopharmaceuticals. Their initial focus is on prostate cancer, with plans to expand to additional disease areas within cancer care.
The approach of Blue Earth Therapeutics is to build on the progress seen with first generation radiopharmaceuticals with unique, targeted radio hybrid agents.
